New migraine drug shows promise in clinical trial
New migraine drug shows promise in clinical trial

New migraine drug shows promise in clinical trial

When migraine sufferers were given ubrogepant versus a placebo, they noticed a significant reduction in pain after two hours.

Latest LiveNOW Stories

From the Archives

Consumer & Money

Science & Tech

Police Chases

Weather Across the Country